Immigrant Ben Liu And TrialSpark Revolutionizing Clinical Trials
Ben Liu, an immigrant from Taiwan, is cofounder and CEO of TrialSpark. TrialSpark The story is as old as America.
Read moreClinical trials
Positive Phase 3 Results for Novel Schizophrenia Drug
The investigational agent xanomeline-trospium (KarXT, Karuna Therapeutics), which combines a muscarinic receptor agonist with an anticholinergic agent, helps improve psychosis
Read moreGene Variants Found to Protect Against Liver Disease
Rare gene variants are associated with a reduced risk for multiple types of liver disease, including cirrhosis, researchers say. People
Read moreIs Prostasin a Clue to Diabetes/Cancer Link?
People with elevated levels of protein prostasin seem to have a higher risk of developing diabetes and dying from cancer,
Read moreIs Lp(a) a Marker for Aortic Calcium Onset?
Lipoprotein(a) has long been thought to be a potential marker of aortic valve disease, and the population-based Rotterdam Study in
Read moreDoes Cannabis Help With Menopause Symptoms?
Many women with symptoms of menopause are turning to cannabis for help, researchers have found, despite a lack of evidence
Read moreMini Robots; Low Uninsured Rate; Primary Care for Cancer
Are Mini Robots Coming to Your Hospital? Super-small robot crabs could one day perform delicate surgical tasks, like repairing small
Read moreAre Mini Robots Coming to Your Hospital?
Imagine being wheeled into the operating room where your surgical team awaits – the surgeon, the anesthesiologist, and … a
Read moreSyneuRx Announces Final Results of Phase 2 Clinical Trial of COVID-19 Oral Antiviral Candidate Pentarlandir® (SNB01) | Business
LOS ANGELES & NEW TAIPEI CITY, Taiwan–(BUSINESS WIRE)–Jul 31, 2022– SyneuRx™ International (TPEX:6575), a global biotech company focused on the
Read moreFDA Approves Topical PDE4-Inhibitor Roflumilast for Psoriasis
The US Food and Drug Administration (FDA) has approved roflumilast 0.3% cream for the topical treatment of plaque psoriasis, “including
Read more